A novel severe acute respiratory syndrome coronavirus (SARS‐CoV‐2) causing lethal acute respiratory disease emerged in December 2019. The World Health Organization named this …
A number of medicines are currently under investigation for the treatment of COVID-19 disease including anti-viral, anti-malarial and anti-inflammatory agents. While these …
H Brave, R MacLoughlin - International Journal of Molecular Sciences, 2020 - mdpi.com
Respiratory and pulmonary diseases are among the leading causes of death globally. Despite tremendous advancements, there are no effective pharmacological therapies …
H Wang, S Luo, M Xie, Z Chen, Y Zhang… - Advanced …, 2024 - Wiley Online Library
Three kinds of coronaviruses are highly pathogenic to humans, and two of them mainly infect humans through Angiotensin‐converting enzyme 2 (ACE2) receptors. Therefore …
AL Thiebes, S Klein, J Zingsheim, GH Möller, S Gürzing… - Pharmaceutics, 2022 - mdpi.com
Cell spraying has become a feasible application method for cell therapy and tissue engineering approaches. Different devices have been used with varying success. Often, twin …
A volume-based Monte Carlo simulation describing the distribution of polydisperse particles aerosolized in polydisperse droplets was developed. The algorithm addressed some major …
Aerosol‐based cell therapy has emerged as a novel and promising therapeutic strategy for treating lung diseases. The goal of this study was to determine the safety and efficacy of …
Airway stem/progenitor epithelial cells (AECs) are notable for their differentiation capacities in response to lung injury. Our previous finding highlighted the regenerative capacity of …